Compare IMA & NBRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMA | NBRG |
|---|---|---|
| Founded | 2019 | 2021 |
| Country | United States | Hong Kong |
| Employees | 17 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 66.3M | 74.5M |
| IPO Year | N/A | 2026 |
| Metric | IMA | NBRG |
|---|---|---|
| Price | $5.97 | $9.96 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $16.00 | N/A |
| AVG Volume (30 Days) | ★ 9.1K | 5.4K |
| Earning Date | 05-15-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.94 | $9.59 |
| 52 Week High | $17.50 | $9.99 |
| Indicator | IMA | NBRG |
|---|---|---|
| Relative Strength Index (RSI) | 56.46 | 55.04 |
| Support Level | $5.36 | $9.94 |
| Resistance Level | $6.08 | $9.99 |
| Average True Range (ATR) | 0.29 | 0.00 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 66.23 | 0.00 |
ImageneBio Inc is a clinical-stage biopharmaceutical company developing therapeutics for patients with immunological, autoimmune and inflammatory diseases. The company's flagship asset, IMG-007, is a non-depleting anti-OX40 monoclonal antibody that binds specifically to OX40 receptor on activated T cells to block receptor binding to OX40 ligand (OX40L). IMG-007 is being developed to potentially treat multiple autoimmune and inflammatory diseases and disorders. The company operates in a single segment.
Newbridge Acquisition Ltd is a blank check company.